Skip to main content
SpringerLink
Log in
Book cover

Totally Implantable Venous Access Devices pp 221–226Cite as

Extravasation

  • Chapter

  • 1209 Accesses

Abstract

Extravasation of vesicant drugs from a port is a real risk caused by catheter damage, incomplete insertion or dislodgement of the needle from the port or fibrin sheath. The focus must be on safe techniques of administration, early detection by close monitoring of the patient and the port and immediate and appropriate management. Accurate and contemporaneous documentation is vital along with education of the patient following extravasation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Polovich M, White JM, Kelleher L (2009) Chemotherapy and biotherapy guidelines and recommendations for practice, 3rd edn. Oncology Nursing Press, Pittsburgh, PA

    Google Scholar 

  2. Schulmeister L (2009) Antineoplastic therapy. In: Alexander M, Corrigan A, Gorski L et al (eds) Infusion therapy: an evidence based approach. Saunders Elsevier, Philadelphia, chapter 18, pp 366–367

    Google Scholar 

  3. Hyde, L, Dougherty, L, Schorstein R (2011) Safe handling of cytotoxic drugs. In: Dougherty L, Lister S (eds) The Royal Marsden NHS Foundation Trust manual of clinical nursing procedures, 8th edn. Wiley Blackwell Publishing, Oxford

    Google Scholar 

  4. Hayden BK, Goodman M (2005) Chemotherapy: principles of administration. In: Henke Yarbro C, Wujcik D, Holmes Gobel B (eds) Cancer nursing-principles and practice, 6th edn. Jones and Bartlett, Boston, MA, pp 351–411

    Google Scholar 

  5. Khan MS, Holmes JD (2002) Reducing morbidity from extravasation injuries. Ann Plast Surg 48:628–632

    Article  PubMed  Google Scholar 

  6. Lawson T (2003) A legal perspective on CVC-related extravasation. J Vasc Access Devices 8:25–27

    Article  Google Scholar 

  7. Masoorli S (2003) Extravasation injuries associated with the use of central vascular access devices. JVAD 8:21–23

    Google Scholar 

  8. Goolsby TV, Lombardo FA (2006) Extravasation of chemo-therapeutic agents: prevention and treatment. Semin Oncol 33:139–143

    Article  PubMed  CAS  Google Scholar 

  9. Dougherty L (2008) Intravenous therapy: recognising the differences between infiltration and extravasation. J British Nurs 17:896–901

    Google Scholar 

  10. EONS (2007) Extravasation guidelines European Oncology Nursing Society

    Google Scholar 

  11. Schulmeister L (1989) Needle dislodgement from implanted venous access devices-inpatients and outpatient experiences. J Intraven Nurs 12:90–92

    PubMed  CAS  Google Scholar 

  12. Mayo DJ (1998) Fibrin sheath formation and chemotherapy extravasation: a case report. Supp Care Cancer 6:51–56

    Article  CAS  Google Scholar 

  13. Weinstein S (2007) Antineoplastic therapy. In: Plumer’s principles and practices of intravenous therapy, 8th edn. Lippincott, Williams & Wilkins, Philadelphia, pp. 486–573

    Google Scholar 

  14. Rudolph R, Larson DL (1987) Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol 5:1116–1126

    PubMed  CAS  Google Scholar 

  15. Bertolli G (1995) Prevention and management of extravasation of cytotoxic drugs. Drug Saf 12:245–255

    Article  Google Scholar 

  16. CP Pharmaceuticals (1999) How quickly could you act? CP Pharmaceuticals, Wrexham

    Google Scholar 

  17. Few BJ (1987) Hyaluronidase for treating intravenous extravasations. MCN Pharmacopoeia 12:23

    CAS  Google Scholar 

  18. Doellmann D, Hadaway L, Bowes-Geddes LA et al (2009) Infiltration and extravasation: update on prevention and management. J Infusion Nurs 32:203–211

    Article  Google Scholar 

  19. Gault D, Challands J (1997) Extravasation of drugs. Anaesth Rev 13:223–241

    Google Scholar 

  20. Wickham R, Engelking C, Sauerland C, Corbi D (2006) Vesicant extravasation part II: evidence based management and continuing controversies. ONF 33:1143–1150

    Article  Google Scholar 

  21. Langer SW, Sehested M, Buhl Jensen P (2000) Treatment of antracycline extravasation dexrazoxane. Clin Cancer Res 6:3680–3686

    PubMed  CAS  Google Scholar 

  22. Mouridsen HT, Langer SW, Butter J et al (2007) Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective multicentre studies. Ann Oncol 18:546–550

    Article  PubMed  CAS  Google Scholar 

  23. Schulmeister L (2007) Totect. A new agent for treating anthracycline extravasation. Clin J Oncol Nurs 11:387–395

    Article  PubMed  Google Scholar 

  24. RCN (2010) Standards for infusion therapy. Royal College of Nursing, London

    Google Scholar 

  25. Dougherty L (2003) An expert witness working within the legal system in the United Kingdom. J Vas Ass Net 8:29–37

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nurse Consultant IV Therapy, The Royal Marsden NHS Foundation Trust, Surrey, UK

    Lisa Dougherty

Authors
  1. Lisa Dougherty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa Dougherty .

Editor information

Editors and Affiliations

  1. Department of Surgical Sciences Organ Transplantation and Advanced Technologies, University of Catania Cannizzaro Hospital, Catania, Italy

    Isidoro Di Carlo

  2. Division of Abdomino Pelvic Surgery, European Institute of Oncology, Milan, Italy

    Roberto Biffi

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Dougherty, L. (2012). Extravasation. In: Di Carlo, I., Biffi, R. (eds) Totally Implantable Venous Access Devices. Springer, Milano. https://doi.org/10.1007/978-88-470-2373-4_31

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2373-4_31

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2372-7

  • Online ISBN: 978-88-470-2373-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation